Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis
暂无分享,去创建一个
Valerie Speirs | Lucy F. Stead | Lucy F Stead | Laura Smith | Andrew M Hanby | V. Speirs | E. Baxter | L. Stead | Laura Smith | A. Hanby | T. Hughes | E. Verghese | P. Chambers | Claire Nash | Thomas A Hughes | Euan W Baxter | Philip A Chambers | Caroline A Green | Claire E Nash | Rebecca A Millican-Slater | Eldo T Verghese | C. Green | R. Millican-Slater
[1] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[2] A. Sacchi,et al. The microRNA miR‐92 increases proliferation of myeloid cells and by targeting p63 modulates the abundance of its isoforms , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Carmen Z. Cantemir-Stone,et al. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. , 2013, American journal of respiratory and critical care medicine.
[4] V. Speirs,et al. Gene Expression of ERβ Isoforms in Laser Microdissected Human Breast Cancers: Implications for Gene Expression Analyses , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[5] A. Blais,et al. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. , 2003, Cancer research.
[6] Sofie Nilsson,et al. Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration , 2012, PloS one.
[7] George A. Calin,et al. GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials , 2010, Nucleic acids research.
[8] Yixuan Hou,et al. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. , 2012, The international journal of biochemistry & cell biology.
[9] T. Tlsty,et al. Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.
[10] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[11] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[12] Victoria Kristina Perry,et al. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients , 2007, International journal of cancer.
[13] Y Magnusson,et al. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer , 2013, Oncogene.
[14] Reuven Agami,et al. miR-148 targets human DNMT3b protein coding region. , 2008, RNA.
[15] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[16] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[17] V. Speirs,et al. Expression of oestrogen receptor beta isoforms is regulated by transcriptional and post-transcriptional mechanisms. , 2010, The Biochemical journal.
[18] J. Steitz,et al. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.
[19] Hsien-Da Huang,et al. miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..
[20] Anwar Hossain,et al. Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA , 2006, Molecular and Cellular Biology.
[21] I. Ellis,et al. Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients , 2008, Clinical Cancer Research.
[22] V. Speirs,et al. Differential regulation of oestrogen receptor β isoforms by 5′ untranslated regions in cancer , 2009, Journal of cellular and molecular medicine.
[23] A. Harris,et al. Gene Expression Analysis in Human Breast Cancer Associated Blood Vessels , 2012, PloS one.
[24] S. Lawler,et al. MicroRNAs in cancer: biomarkers, functions and therapy. , 2014, Trends in molecular medicine.
[25] V. Speirs,et al. Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. , 2010, Cancer research.
[26] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[27] Nectarios Koziris,et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support , 2011, Nucleic Acids Res..
[28] S. Ropero,et al. A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.
[29] P. Tan,et al. Identification of Circulating MicroRNA Signatures for Breast Cancer Detection , 2013, Clinical Cancer Research.
[30] Jiri Zavadil,et al. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation , 2011, The EMBO journal.
[31] Robert A. Weinberg,et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.
[32] Valerie Speirs,et al. MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion , 2013, The Journal of pathology.
[33] Metin N. Gurcan,et al. Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors , 2009, Nature.
[34] L. Shea,et al. Transcription Factor Networks in Invasion-Promoting Breast Carcinoma-Associated Fibroblasts , 2013, Cancer Microenvironment.
[35] M J Bissell,et al. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.
[36] D. Allred,et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[37] H. Moses,et al. Disruption of bone morphogenetic protein receptor 2 (BMPR2) in mammary tumors promotes metastases through cell autonomous and paracrine mediators , 2011, Proceedings of the National Academy of Sciences.
[38] Tara L. Naylor,et al. microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[39] Jun Yao,et al. Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.
[40] Peter A. Jones,et al. Epigenetic Activation of Tumor Suppressor MicroRNAs in Human Cancer Cells , 2006, Cell cycle.
[41] Yingjian Chen,et al. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer , 2012, Journal of Cancer Research and Clinical Oncology.
[42] Xabier Agirre,et al. Epigenetic regulation of microRNA expression in colorectal cancer , 2009, International journal of cancer.
[43] G. Scambia,et al. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer. , 2014, Gynecologic oncology.
[44] Rudolf Jaenisch,et al. Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.
[45] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[46] Terry Hyslop,et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.
[47] John N Weinstein,et al. A stromal gene signature associated with inflammatory breast cancer , 2008, International journal of cancer.
[48] Jarret Glasscock,et al. Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank , 2014, Breast Cancer Research.
[49] Martin Clynes,et al. BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome , 2013, Breast Cancer Research.
[50] Bo Zhang,et al. Distinct MicroRNA Subcellular Size and Expression Patterns in Human Cancer Cells , 2012, International journal of cell biology.
[51] V. Speirs,et al. Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts , 2012, The Journal of pathology.